Showing results (1-10 of 85) with videos related to
Sort By:
Pageof 9
Seminars in Perinatology|November 7, 1999
First trimester screening for aneuploidy: serum biochemical markersJ A Canick, L H KellnerPrenatal Diagnosis|October 16, 1999
Collaborative study of maternal urine beta -core human chorionic gonadotrophin screening for Down syndromeH S Cuckle, J A Canick, L H KellnerMolecular Medicine Today|April 14, 1999
Urinary analyte screening: a noninvasive detection method for Down syndrome?J A Canick, L H Kellner, L A Cole, et al.Prenatal Diagnosis|August 1, 1995
Second-trimester levels of maternal urinary gonadotropin peptide in Down syndrome pregnancyJ A Canick, L H Kellner, D N Saller, et al.The Journal of Maternal-Fetal Medicine|May 3, 2001
Maternal serum levels of type I and type III procollagen peptides in pre-eclamptic pregnancyH Yamamoto, G M Lambert-Messerlian, H M Silver, et al.Obstetrics and Gynecology|July 1, 1997
Serum triple-marker screening in in vitro fertilization and naturally conceived pregnanciesG N Frishman, J A Canick, J W Hogan, et al.American Journal of Obstetrics and Gynecology|November 25, 1997
Maternal serum analyte levels in pregnancies with fetal Down syndrome resulting from translocationsD N Saller, J A Canick, L H Kellner, et al.Prenatal Diagnosis|July 1, 1997
Comparison of 12 assays for detecting hCG and related molecules in urine samples from Down syndrome pregnanciesL A Cole, L H Kellner, T Isozaki, et al.Prenatal Diagnosis|February 19, 1998
Levels of urinary beta-core fragment, total oestriol, and the ratio of the two in second-trimester screening for Down syndromeL H Kellner, J A Canick, G E Palomaki, et al.Obstetrics and Gynecology Clinics of North America|September 1, 1993
Maternal serum screening for aneuploidy and open fetal defectsJ A Canick, D N SallerPageof 9